Clinical Trials Browser

OTHER × Thymoma × Nivolumab × Clear all

NCT03583086 2024-10-08

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

Phase 1/2 Completed

88 enrolled 20 charts

Carcinoma, Non-Small-Cell Lung, Thymoma, Small Cell Lung Carcinoma